| 000 | 01884 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516161720.0 | ||
| 264 | 0 | _c20140414 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1873-4995 | ||
| 024 | 7 |
_a10.1016/j.jconrel.2013.06.038 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaslov, Mikhail Y | |
| 245 | 0 | 0 |
_aHigh concentrations of drug in target tissues following local controlled release are utilized for both drug distribution and biologic effect: an example with epicardial inotropic drug delivery. _h[electronic resource] |
| 260 |
_bJournal of controlled release : official journal of the Controlled Release Society _cOct 2013 |
||
| 300 |
_a201-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlginates _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium _xchemistry |
| 650 | 0 | 4 |
_aCardiotonic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 |
_aDelayed-Action Preparations _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 |
_aEpinephrine _xadministration & dosage |
| 650 | 0 | 4 |
_aGlucuronic Acid _xchemistry |
| 650 | 0 | 4 |
_aHeart Ventricles _xmetabolism |
| 650 | 0 | 4 |
_aHexuronic Acids _xchemistry |
| 650 | 0 | 4 | _aHydrogels |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aPericardium _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aEdelman, Elazer R | |
| 700 | 1 | _aWei, Abraham E | |
| 700 | 1 | _aPezone, Matthew J | |
| 700 | 1 | _aLovich, Mark A | |
| 773 | 0 |
_tJournal of controlled release : official journal of the Controlled Release Society _gvol. 171 _gno. 2 _gp. 201-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jconrel.2013.06.038 _zAvailable from publisher's website |
| 999 |
_c22934536 _d22934536 |
||